Skip to main content
Premium Trial:

Request an Annual Quote

iPS on the Way

Two teams report creating mice from iPS cells. In Nature, researchers led by the Chinese Academy of Sciences' Qi Zhou followed Kyoto University's Shinya Yamanaka's protocol and used viral vectors to introduce four factors into mouse fibroblast cells to reprogram them. Zhou's group was able to get 27 live mouse births with their best method getting 22 live births at a success rate of 3.5 percent. In Cell Stem Cell, National Institute of Biological Sciences in Beijing's Shaorong Gao's team used a similar technique to yield two live births at 1.1 percent success rate, though one died soon thereafter. "They have shown that iPS cells can satisfy the most stringent criteria of pluripotency," Harvard's George Daley says in Wired. His colleague Konrad Hochedlinger adds in the Washington Post that "this clearly says for the first time that iPS cells pass the most stringent test." However, this doesn't mean that iPS cells are identical to embryonic stem cells. "Here's another way in which these cells are functionally similar to [embryonic stem cells], but it's not to say that they're identical," University of Michigan's Sean Morrison says, also in Wired.

The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.